Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Resolution voted by shareholders, to allow the issue of £1,068, 378.08p worth of shares. RM has virtually used the quota allowed. Mainly on working capital.
RNS 26th March
The Company has raised £780,000 by way of a Subscription ("Subscription"), through the issue of 260,000,000 new Ordinary Shares of £0.001 in the Company ("Subscription Shares") at a price of £0.003 per Subscription Share.
The funds will be used for working capital by the Company and its subsidiaries.
The admission of the Subscription Shares to trading is conditional upon approval of a prospectus by the Financial Conduct Authority ("FCA").
RNS 23rd January
The Company has raised £140,000 by way of a Subscription ("Subscription"), through the issue of 46,666,667 new Ordinary Shares of £0.001 in the Company ("Subscription Shares") at a price of £.0.003 per Subscription Share.
The admission of the Subscription Shares to trading is conditional upon approval of a prospectus by the Financial Conduct Authority ("FCA").
RNS 14th November
In addition, as part of the transaction the parent company of the Lender shall receive 13,000,000 new Ordinary Shares of £0.001 in the Company ("Fee Shares"). The admission of the Fee Shares to trading is conditional upon approval of a prospectus by the Financial Conduct Authority.
RNS 29th September
is pleased to announce it has raised £92,750 by way of Subscription ("Subscription"), through the issue of 30,916,667 new Ordinary Shares of £0.001 in the Company ("Ordinary Shares") at a price of £0.003 per Ordinary Share (the "Subscription Price").
The issue of the new Ordinary Shares to trading is conditional upon approval of a prospectus by the Financial Conduct Authority ("FCA"). Caracal continues to progress the prospectus through the FCA.
Following publication of the results, we will aim to finalise the prospectus with the FCA as soon as possible.
From what shareholders have voted on the PROSPECTUS it should contain £1,068, 378.08p worth of shares, RM has been forwarded issuing them at 0.3p, since 29th September RNS.
Looks to me like there's around £16.6k left in the issuing pot and therefore nothing more material is left to gain from the prospectus.
Happy to be corrected.
I've dealt with numerous board members in various companies on a professional level.
Some are more engaging than others regarding shareholders but they all understand that a shareholder today may not be a shareholder tomorrow, therefore the behind the scenes mindset is quite different to the public perception put forward.
A big misconception for shareholders is to feel truly aligned with insiders.
Zan I think the $millions wasted on Tanzania will be dead money for several years to come but it was used straight away to make the company look bigger than it is.
Kilimapesa is 670k - 700k ounces producing resource whereby Tanzania's 600k ounce resource will probably won't happen for at least 5years (if it ever does).
Combined resources are 1.3m ounces, a bit of smoke and mirrors to make it look like 1.3m ounces on a producing resource.
'Caracal Gold PLC, the expanding East African gold producer with over 1,300,000oz JORC compliant gold resources'
Generally, when a company moves away from the structure of quarterly updates, it's not going to be good news for shareholders.
The last quarterly update here was Q2 2023, that update contained increased production figures from the high-grade zone material.
The high-grade was forecast by the company to be used up by the end of Q2.
There's been no further update on whether more has been found, therefore the production from Q3 onwards has only contained low-grade material.
Also, some of the equipment has been stood down pending upgrades, which will have a dramatic effect on the production levels from Q2.
The high-grade material was used up last June they should have been exploring for more if they were really going to turn it around.
It's going to be incredibly hard for anyone using low-grade material to make it truly viable.
Zan, I 8 bagged plus in HE1 after a horrendous discounted placing and following sell off.
Position size is the key, I took a hit here after OCIM and decided to leave an amount I'm comfortable to hold here. If the company does well I can increase if not and I fancy my chances after a big sell off I could also increase.
Keep all options on the table but going in big early is a recipe for wipe out as many are finding out here.
This extract is from a RNS released today in another company, spot the difference with the GCAT RNS and you're deliberately left to make you're own interpretation of the timeline.
The net proceeds of the Subscription will provide the Company with working capital to support the strategy to progress... through the next 16 months on the Company's current cost basis.
GCAT RNS
The funds will be used for working capital by the Company and its subsidiaries.
I don't rule anything out with small caps.
Everything contained within a RNS is always open to interpretation. The latest raise was for working capital for the company and it's subsidiaries.
Working capital funding refers to the financial resources a company uses to cover its day-to-day operational expenses and short-term liabilities. It's essential for sustaining regular business activities, such as purchasing inventory, paying salaries, and covering utility bills.